Literature DB >> 7997728

Role of radiation in the management of adult patients with sarcoma of soft tissue.

H D Suit1, I Spiro.   

Abstract

Radiation in moderate dose levels, viz. 60-65 Gy at 2 Gy/fraction, administered in combination with conservative surgery, yields local control frequencies at least comparable to those achieved by radical resectional surgery alone. The clinical interest in this management strategy is the reduction in the scope of the resection and a consequent gain in cosmetic and functional status. This combined approach is favored for sarcomas so situated that resection with wide margin, > or = 2 cm at the most narrow, cannot be realized unless there is a clinically important loss in function. Where radical surgery is planned, there must be great care in assessment of the probability of achieving good margins. The patient is ill served if there is radical surgery and then, because of close margins, postoperative radiation is required. There appears to be clinical gain for the patient with a large sarcoma by administering the radiation preoperatively. Advantages include smaller treatment volume and higher local control rates. The management of the surgical wound in the irradiated patient is discussed. Also, brief consideration is given to current use of brachytherapy, high linear energy transfer (LET) radiation, and combination of radiation and chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997728     DOI: 10.1002/ssu.2980100507

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  6 in total

1.  Leiomyosarcoma of the Face.

Authors:  Young-Il Ko; Jin-Soo Lim; Ki-Taik Han; Min-Cheol Kim
Journal:  Arch Craniofac Surg       Date:  2014-04-10

2.  [Consensus diagnosis and therapy of soft tissue sarcoma].

Authors:  Thomas Brodowicz; Gabriele Amann; Andreas Leithner; Arpad Sztankay; Franz Kainberger; Wolfgang Eisterer; Bernadette Liegl-Atzwanger; Franz Rachbauer; Thomas Rath; Michael Bergmann; Philipp T Funovics; Ferdinand Ploner; Reinhard Windhager
Journal:  Wien Klin Wochenschr       Date:  2011-10-28       Impact factor: 1.704

3.  Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.

Authors:  Nicholas P Gannon; Matthew H Stemm; David M King; Meena Bedi
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-07       Impact factor: 4.553

4.  High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy.

Authors:  Benedikt Leidinger; Thomas Heyse; Andreas Schuck; Horst Buerger; Philipp Mommsen; Thomas Bruening; Susanne Fuchs; Georg Gosheger
Journal:  BMC Cancer       Date:  2006-06-18       Impact factor: 4.430

5.  Tumor volume is a better predictor of post-operative wound complications compared to tumor size in soft tissue sarcomas of the proximal lower extremity.

Authors:  Michael Ziegele; David M King; Manpreet Bedi
Journal:  Clin Sarcoma Res       Date:  2016-02-22

6.  Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy.

Authors:  Nicholas P Gannon; David M King; Manpreet Bedi
Journal:  Clin Sarcoma Res       Date:  2018-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.